Assessment of the effect of vitamin E supplementation on the ocular tear film

ISRCTN ISRCTN39888829
DOI https://doi.org/10.1186/ISRCTN39888829
Sponsor King Saud University
Funder College of Medicine, King Saud University
Submission date
29/09/2026
Registration date
01/10/2026
Last edited
01/10/2026
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Gamal El-Hiti
Scientific, Public, Principal investigator

Department of Optometry, College of Applied Medical Sciences, King Saud University
Riyadh 11433
P.O. BOX 10219
Saudi Arabia

ORCiD logoORCID ID 0000-0001-6675-3126
Phone +966 0114693778
Email gelhiti@ksu.edu.sa

Study information

Primary study designInterventional
AllocationNon-randomized controlled trial
MaskingBlinded (masking used)
ControlPlacebo
AssignmentParallel
PurposeBasic science
Participant information sheet 50368_PIS.pdf
Scientific titlePotential benefits of short-term vitamin E supplementation for the ocular tear film: A randomized controlled trial
Study acronymVIT-E
Study objectives Randomized controlled trial
Ethics approval(s)

Approved 24/11/2025, Institutional Review Board (IRB) at King Saud University (Health Sciences Colleges Researches on Human Subjects, King Saud University, Riyadh, 11461, Saudi Arabia; +966 0114691529; fbashiri@ksu.edu.sa), ref: E-25-10201

Health condition(s) or problem(s) studiedImpact of vitamin E on the ocular tear film
InterventionParticipants will receive oral vitamin E supplementation consisting of one JP Natural Vitamin E 400 IU softgel capsule (containing 268 mg natural alpha-tocopherol) taken once daily for three consecutive days. Baseline assessments will be conducted before supplementation and will include completion of the Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire and tear film evaluations comprising non-invasive tear breakup time (NITBUT), tear meniscus height (TMH), and tear ferning (TF) tests. Participants will attend a follow-up visit 24 hours after the third vitamin E dose, during which the SPEED questionnaire and all tear film assessments will be repeated to evaluate changes in subjective symptoms of ocular dryness and objective tear film parameters. The control group will receive placebo capsules for comparison, and we will obtain measurements on days 1 and 4.
Intervention typeSupplement
Primary outcome measure(s)
  1. Ocular tear film parameters measured using the Standard Patient Evaluation of Eye Dryness (SPEED) questionnaire at day 1 and 4
  2. Noninvasive tear breakup time (NITBUT) measured using the EasyTear View+ device at day 1 and 4
  3. Tear meniscus height (TMH) measured using the EasyTear View+ device (mm) at day 1 and 4
  4. Tear ferning (TF) measured using microscopic examination of dried tear samples using a five-point grading scale (Grade) at day 1 and 4
Key secondary outcome measure(s)
Completion date30/03/2026

Eligibility

Participant type(s)
Age groupAdult
Lower age limit18 Years
Upper age limit27 Years
SexAll
Target sample size at registration64
Total final enrolment64
Key inclusion criteria1. Healthy adults without eye diseases or disorders
2. Individuals who do not wear contact lenses
3. Have not undergone ocular surgery
4. Do not have high blood pressure
Key exclusion criteriaNot meeting the key inclusion criteria
Date of first enrolment06/01/2026
Date of final enrolment26/03/2026

Locations

Countries of recruitment

  • Saudi Arabia

Study participating centres

Results and Publications

Individual participant data (IPD) Intention to shareNo

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet 30/09/2026 No Yes
Protocol file 01/10/2026 No No
Statistical Analysis Plan 01/10/2026 No No

Additional files

50368_PIS.pdf
Participant information sheet
50368_Protocol.pdf
Protocol file
50368_Protocol.pdf
Statistical Analysis Plan

Editorial Notes

30/09/2026: Study’s existence confirmed by the King Saud University Medical City, Institutional Review Board (IRB), Human Subject Researches.